Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mason W Freeman

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Kidney International|September 17, 2015
Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemiaDavid A Bushinsky, Gordon H Williams, Bertram Pitt, et al.
JAMA|July 15, 2015
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical TrialGeorge L Bakris, Bertram Pitt, Matthew R Weir, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathwaysPhilipp Henneke, Osamu Takeuchi, Richard Malley, et al.
The New England Journal of Medicine|November 7, 2022
Phase 2 Trial of Baxdrostat for Treatment-Resistant HypertensionMason W Freeman, Yuan-Di Halvorsen, William Marshall, et al.
The Journal of Biological Chemistry|October 12, 2002
Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophagesVidya V Kunjathoor, Maria Febbraio, Eugene A Podrez, et al.
The Annals of Otology, Rhinology, and Laryngology|November 22, 2011
Local injection of bevacizumab (Avastin) and angiolytic KTP laser treatment of recurrent respiratory papillomatosis of the vocal folds: a prospective studySteven M Zeitels, Anca M Barbu, Tali Landau-Zemer, et al.
Physiological Genomics|September 16, 2004
The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascadesHarry Björkbacka, Katherine A Fitzgerald, François Huet, et al.
The Annals of Otology, Rhinology, and Laryngology|September 28, 2012
Safety and dosing of bevacizumab (avastin) for the treatment of recurrent respiratory papillomatosisSimon R Best, Aaron D Friedman, Tali Landau-Zemer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 19, 2019
Safety and Effectiveness of Bexagliflozin in Patients With Type 2 Diabetes Mellitus and Stage 3a/3b CKDAndrew S Allegretti, Wenbin Zhang, Wenjiong Zhou, et al.
The Journal of Biological Chemistry|November 20, 2004
Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levelsWoojin Scott Kim, Michael L Fitzgerald, Kihwa Kang, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Kidney International|September 17, 2015
Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemiaDavid A Bushinsky, Gordon H Williams, Bertram Pitt, et al.
JAMA|July 15, 2015
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical TrialGeorge L Bakris, Bertram Pitt, Matthew R Weir, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathwaysPhilipp Henneke, Osamu Takeuchi, Richard Malley, et al.
The New England Journal of Medicine|November 7, 2022
Phase 2 Trial of Baxdrostat for Treatment-Resistant HypertensionMason W Freeman, Yuan-Di Halvorsen, William Marshall, et al.
The Journal of Biological Chemistry|October 12, 2002
Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophagesVidya V Kunjathoor, Maria Febbraio, Eugene A Podrez, et al.
The Annals of Otology, Rhinology, and Laryngology|November 22, 2011
Local injection of bevacizumab (Avastin) and angiolytic KTP laser treatment of recurrent respiratory papillomatosis of the vocal folds: a prospective studySteven M Zeitels, Anca M Barbu, Tali Landau-Zemer, et al.
Physiological Genomics|September 16, 2004
The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascadesHarry Björkbacka, Katherine A Fitzgerald, François Huet, et al.
The Annals of Otology, Rhinology, and Laryngology|September 28, 2012
Safety and dosing of bevacizumab (avastin) for the treatment of recurrent respiratory papillomatosisSimon R Best, Aaron D Friedman, Tali Landau-Zemer, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 19, 2019
Safety and Effectiveness of Bexagliflozin in Patients With Type 2 Diabetes Mellitus and Stage 3a/3b CKDAndrew S Allegretti, Wenbin Zhang, Wenjiong Zhou, et al.
The Journal of Biological Chemistry|November 20, 2004
Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levelsWoojin Scott Kim, Michael L Fitzgerald, Kihwa Kang, et al.
Pageof 7